Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Tasbakan (Izmir, Turkey), L. Grote (Gothenburg, Sweden), J. Hedner (Gothenburg, Sweden), J. Kvamme (Forde, Norway), J. Verbraecken (Antwerp, Belgium), W. Mcnicholas (Dublin, Ireland), G. Roisman (Clamart, France), R. Tkacova (Kosice, Slovakia), M. Bonsignore (Palermo, Italy), T. Saaresranta (Turku, Finland), P. Steiropoulos (Alexandroupolis, Greece), O. Basoglu (Izmir, Turkey). Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA. 2007

Member's Comments

No comment yet.

Related content which might interest you: Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA1c) even in euglycemic obstructive sleep apnoea patients within normal HbA1c range Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Association between plasma haemoglobin A1c (HbA1c) concentration and overnight desaturation in obstructive sleep apnoea (OSA) patients without diabetes Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Glycosylated hemoglobin (HbA1c) in adults with obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 492s Year: 2007 The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Childhood obstructive sleep apnoea and elevated blood pressure: A longitudinal follow-up study Source: Annual Congress 2012 - Paediatrics and sleep apnoea/adults and upper airway stimulation Year: 2012 Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA) Source: Sleep and Breathing Conference 2021 Year: 2021 Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020 Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Continuous positive airway pressure in patients with obstructive sleep apnea: Adherence dependent on apnea-hypopnea index, leakage and mask pressure Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea Year: 2011 Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Plasma endothelin-1 (ET-1) levels in obstructive sleep apnea (OSA) patients and effect of continouous positive airway pressure (CPAP) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Blood pressure reduction following treatment with positive airway pressure in sleep apnea – data from the ESADA Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Factors influencing the level of efficient pressure of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSAS) Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea Year: 2016